Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
marked decrease » marked increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
day mean » may mean (Expand Search), daily mean (Expand Search), data mean (Expand Search)
Showing 1 - 20 results of 1,536 for search '(( third ((((marked decrease) OR (a decrease))) OR (greater decrease)) ) OR ( day mean decrease ))', query time: 0.58s Refine Results
  1. 1
    Individual and mean EQ-5D VAS scores in the PP-group (0 = baseline, 1 = after the first day of treatment, 2 = after the second day of treatment, 3 = after the third day of treatment, 4 = after the fourth day of treatment, 5 = after all treatments, 35 = at the 30-day follow-up).

    Individual and mean EQ-5D VAS scores in the PP-group (0 = baseline, 1 = after the first day of treatment, 2 = after the second day of treatment, 3 = after the third day of treatmen... by Marcus Persson (20496333)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Effect of anti-<i>Leishmania</i> drugs added to a sugar diet on the longevity of <i>Lu. longipalpis</i> females.

    Effect of anti-<i>Leishmania</i> drugs added to a sugar diet on the longevity of <i>Lu. longipalpis</i> females. by Tainá Neves Ferreira (21601579)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Effect of anti-<i>Leishmania</i> drugs added to a sugar diet on the longevity of <i>Lu. longipalpis</i> males.

    Effect of anti-<i>Leishmania</i> drugs added to a sugar diet on the longevity of <i>Lu. longipalpis</i> males. by Tainá Neves Ferreira (21601579)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Effect of anti-<i>Leishmania</i> compounds added to a sugar diet on females of <i>Lu. longipalpis</i> pre and post-blood feeding.

    Effect of anti-<i>Leishmania</i> compounds added to a sugar diet on females of <i>Lu. longipalpis</i> pre and post-blood feeding. by Tainá Neves Ferreira (21601579)

    Published 2025
    Save to List
    Saved in:
  5. 5
    Top: Individual Montgomery-Åsberg Depression Rating Scale (MADRS) scores in the PP-group.

    Top: Individual Montgomery-Åsberg Depression Rating Scale (MADRS) scores in the PP-group. by Marcus Persson (20496333)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Quantification of ingested proteins by females after 30 minutes of blood feeding.

    Quantification of ingested proteins by females after 30 minutes of blood feeding. by Tainá Neves Ferreira (21601579)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Third.

    Third. by Cuicui Liu (1496260)

    Published 2024
    Save to List
    Saved in:
  8. 8
    Average days (mean) to heal a wound in 2022 and 2023.

    Average days (mean) to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Geometric mean anti-<i>Na</i>-GST-1 IgG subclass levels over time.

    Geometric mean anti-<i>Na</i>-GST-1 IgG subclass levels over time. by David J. Diemert (8135568)

    Published 2024
    Save to List
    Saved in:
  10. 10
    Association between the mean of the daily mean temperatures for the previous 7 days and AAD onset by subset analysis.

    Association between the mean of the daily mean temperatures for the previous 7 days and AAD onset by subset analysis. by Ayami Ishikawa (19838027)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 11
    Heteroscedastic linear mixed model main results, estimating the volume (ml) of beer sold per day on the transformed (cube root) scale, on the original scale and on the relative scale, covariate coefficients shown in Table A in S3 Appendix (<i>n</i> = 12).

    Heteroscedastic linear mixed model main results, estimating the volume (ml) of beer sold per day on the transformed (cube root) scale, on the original scale and on the relative sca... by Eleni Mantzari (6991172)

    Published 2024
    Save to List
    Saved in:
  12. 12
    Cronbach’s alpha and means the stigma of Suicide Scale Short Form (SOSS-SF).

    Cronbach’s alpha and means the stigma of Suicide Scale Short Form (SOSS-SF). by Orrin D. Ware (14829115)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  14. 14
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  15. 15
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Mean cocaine consumed (mg/kg) over 10 days.

    Mean cocaine consumed (mg/kg) over 10 days. by Christopher Rowan (21499924)

    Published 2025
    Save to List
    Saved in:
  18. 18
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  19. 19
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  20. 20
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:

Search Tools: